Abstract
Background: Human immunodeficiency virus and acquired immune deficiency syndrome (HIV/AIDS) is still among the leading causes of disease burden and mortality in sub-Saharan Africa (SSA), and the world is not on track to meet targets set for ending the epidemic by the Joint United Nations Programme on HIV/AIDS (UNAIDS) and the United Nations Sustainable Development Goals (SDGs). Precise HIV burden information is critical for effective geographic and epidemiological targeting of prevention and treatment interventions. Age- and sex-specific HIV prevalence estimates are widely available at the national level, and region-wide local estimates were recently published for adults overall. We add further dimensionality to previous analyses by estimating HIV prevalence at local scales, stratified into sex-specific 5-year age groups for adults ages 15–59 years across SSA. Methods: We analyzed data from 91 seroprevalence surveys and sentinel surveillance among antenatal care clinic (ANC) attendees using model-based geostatistical methods to produce estimates of HIV prevalence across 43 countries in SSA, from years 2000 to 2018, at a 5 × 5-km resolution and presented among second administrative level (typically districts or counties) units. Results: We found substantial variation in HIV prevalence across localities, ages, and sexes that have been masked in earlier analyses. Within-country variation in prevalence in 2018 was a median 3.5 times greater across ages and sexes, compared to for all adults combined. We note large within-district prevalence differences between age groups: for men, 50% of districts displayed at least a 14-fold difference between age groups with the highest and lowest prevalence, and at least a 9-fold difference for women. Prevalence trends also varied over time; between 2000 and 2018, 70% of all districts saw a reduction in prevalence greater than five percentage points in at least one sex and age group. Meanwhile, over 30% of all districts saw at least a five percentage point prevalence increase in one or more sex and age group. Conclusions: As the HIV epidemic persists and evolves in SSA, geographic and demographic shifts in prevention and treatment efforts are necessary. These estimates offer epidemiologically informative detail to better guide more targeted interventions, vital for combating HIV in SSA.
Original language | English |
---|---|
Article number | 488 |
Journal | BMC Medicine |
Volume | 20 |
Issue number | 1 |
DOIs | |
Publication status | Published - Dec 2022 |
Keywords
- Africa
- Demographics
- Geostatistics
- HIV
- HIV prevalence
- Mapping
- Spatial statistics
Access to Document
Other files and links
Fingerprint
Dive into the research topics of 'Mapping age- and sex-specific HIV prevalence in adults in sub-Saharan Africa, 2000–2018'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: BMC Medicine, Vol. 20, No. 1, 488, 12.2022.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Mapping age- and sex-specific HIV prevalence in adults in sub-Saharan Africa, 2000–2018
AU - on behalf of Local Burden of Disease sub-Saharan Africa HIV Prevalence Collaborators
AU - Haeuser, Emily
AU - Serfes, Audrey L.
AU - Cork, Michael A.
AU - Yang, Mingyou
AU - Abbastabar, Hedayat
AU - Abhilash, E. S.
AU - Adabi, Maryam
AU - Adebayo, Oladimeji M.
AU - Adekanmbi, Victor
AU - Adeyinka, Daniel Adedayo
AU - Afzal, Saira
AU - Ahinkorah, Bright Opoku
AU - Ahmadi, Keivan
AU - Ahmed, Muktar Beshir
AU - Akalu, Yonas
AU - Akinyemi, Rufus Olusola
AU - Akunna, Chisom Joyqueenet
AU - Alahdab, Fares
AU - Alanezi, Fahad Mashhour
AU - Alanzi, Turki M.
AU - Alene, Kefyalew Addis
AU - Alhassan, Robert Kaba
AU - Alipour, Vahid
AU - Almasi-Hashiani, Amir
AU - Alvis-Guzman, Nelson
AU - Ameyaw, Edward Kwabena
AU - Amini, Saeed
AU - Amugsi, Dickson A.
AU - Ancuceanu, Robert
AU - Anvari, Davood
AU - Appiah, Seth Christopher Yaw
AU - Arabloo, Jalal
AU - Aremu, Olatunde
AU - Asemahagn, Mulusew A.
AU - Jafarabadi, Mohammad Asghari
AU - Awedew, Atalel Fentahun
AU - Quintanilla, Beatriz Paulina Ayala
AU - Ayanore, Martin Amogre
AU - Aynalem, Yared Asmare
AU - Azari, Samad
AU - Azene, Zelalem Nigussie
AU - Darshan, B. B.
AU - Babalola, Tesleem Kayode
AU - Baig, Atif Amin
AU - Banach, Maciej
AU - Bärnighausen, Till Winfried
AU - Bell, Arielle Wilder
AU - Bhagavathula, Akshaya Srikanth
AU - Bhardwaj, Nikha
AU - Bhardwaj, Pankaj
AU - Bhattacharyya, Krittika
AU - Bijani, Ali
AU - Bitew, Zebenay Workneh
AU - Bohlouli, Somayeh
AU - Bolarinwa, Obasanjo Afolabi
AU - Boloor, Archith
AU - Bozicevic, Ivana
AU - Butt, Zahid A.
AU - Cárdenas, Rosario
AU - Carvalho, Felix
AU - Charan, Jaykaran
AU - Chattu, Vijay Kumar
AU - Chowdhury, Mohiuddin Ahsanul Kabir
AU - Chu, Dinh Toi
AU - Cowden, Richard G.
AU - Dahlawi, Saad M.A.
AU - Damiani, Giovanni
AU - Darteh, Eugene Kofuor Maafo
AU - Darwesh, Aso Mohammad
AU - das Neves, José
AU - Weaver, Nicole Davis
AU - De Leo, Diego
AU - De Neve, Jan Walter
AU - Deribe, Kebede
AU - Deuba, Keshab
AU - Dharmaratne, Samath
AU - Dianatinasab, Mostafa
AU - Diaz, Daniel
AU - Didarloo, Alireza
AU - Djalalinia, Shirin
AU - Dorostkar, Fariba
AU - Dubljanin, Eleonora
AU - Duko, Bereket
AU - El Tantawi, Maha
AU - El-Jaafary, Shaimaa I.
AU - Eshrati, Babak
AU - Eskandarieh, Sharareh
AU - Eyawo, Oghenowede
AU - Ezeonwumelu, Ifeanyi Jude
AU - Ezzikouri, Sayeh
AU - Farzadfar, Farshad
AU - Fattahi, Nazir
AU - Fauk, Nelsensius Klau
AU - Fernandes, Eduarda
AU - Filip, Irina
AU - Fischer, Florian
AU - Foigt, Nataliya A.
AU - Foroutan, Masoud
AU - Fukumoto, Takeshi
AU - Gad, Mohamed M.
AU - Gaidhane, Abhay Motiramji
AU - Gebregiorgis, Birhan Gebresillassie
AU - Gebremedhin, Ketema Bizuwork
AU - Getacher, Lemma
AU - Ghadiri, Keyghobad
AU - Ghashghaee, Ahmad
AU - Golechha, Mahaveer
AU - Gubari, Mohammed Ibrahim Mohialdeen
AU - Gugnani, Harish Chander
AU - Guimarães, Rafael Alves
AU - Haider, Mohammad Rifat
AU - Haj-Mirzaian, Arvin
AU - Hamidi, Samer
AU - Hashi, Abdiwahab
AU - Hassanipour, Soheil
AU - Hassankhani, Hadi
AU - Hayat, Khezar
AU - Herteliu, Claudiu
AU - Ho, Hung Chak
AU - Holla, Ramesh
AU - Hosseini, Mostafa
AU - Hosseinzadeh, Mehdi
AU - Hwang, Bing Fang
AU - Ibitoye, Segun Emmanuel
AU - Ilesanmi, Olayinka Stephen
AU - Ilic, Irena M.
AU - Ilic, Milena D.
AU - Islam, Rakibul M.
AU - Iwu, Chidozie C.D.
AU - Jakovljevic, Mihajlo
AU - Jha, Ravi Prakash
AU - Ji, John S.
AU - Johnson, Kimberly B.
AU - Joseph, Nitin
AU - Joshua, Vasna
AU - Joukar, Farahnaz
AU - Jozwiak, Jacek Jerzy
AU - Kalankesh, Leila R.
AU - Kalhor, Rohollah
AU - Kamyari, Naser
AU - Kanchan, Tanuj
AU - Matin, Behzad Karami
AU - Karimi, Salah Eddin
AU - Kayode, Gbenga A.
AU - Karyani, Ali Kazemi
AU - Keramati, Maryam
AU - Khan, Ejaz Ahmad
AU - Khan, Gulfaraz
AU - Khan, Md Nuruzzaman
AU - Khatab, Khaled
AU - Khubchandani, Jagdish
AU - Kim, Yun Jin
AU - Kisa, Adnan
AU - Kisa, Sezer
AU - Kopec, Jacek A.
AU - Kosen, Soewarta
AU - Laxminarayana, Sindhura Lakshmi Koulmane
AU - Koyanagi, Ai
AU - Krishan, Kewal
AU - Defo, Barthelemy Kuate
AU - Kugbey, Nuworza
AU - Kulkarni, Vaman
AU - Kumar, Manasi
AU - Kumar, Nithin
AU - Kusuma, Dian
AU - La Vecchia, Carlo
AU - Lal, Dharmesh Kumar
AU - Landires, Iván
AU - Larson, Heidi Jane
AU - Lasrado, Savita
AU - Lee, Paul H.
AU - Li, Shanshan
AU - Liu, Xuefeng
AU - Maleki, Afshin
AU - Malik, Preeti
AU - Mansournia, Mohammad Ali
AU - Martins-Melo, Francisco Rogerlândio
AU - Mendoza, Walter
AU - Menezes, Ritesh G.
AU - Mengesha, Endalkachew Worku
AU - Meretoja, Tuomo J.
AU - Mestrovic, Tomislav
AU - Mirica, Andreea
AU - Moazen, Babak
AU - Mohamad, Osama
AU - Mohammad, Yousef
AU - Mohammadian-Hafshejani, Abdollah
AU - Mohammadpourhodki, Reza
AU - Mohammed, Salahuddin
AU - Mohammed, Shafiu
AU - Mokdad, Ali H.
AU - Moradi, Masoud
AU - Moraga, Paula
AU - Mubarik, Sumaira
AU - Mulu, Getaneh Baye B.
AU - Mwanri, Lillian
AU - Nagarajan, Ahamarshan Jayaraman
AU - Naimzada, Mukhammad David
AU - Naveed, Muhammad
AU - Nazari, Javad
AU - Ndejjo, Rawlance
AU - Negoi, Ionut
AU - Ngalesoni, Frida N.
AU - Nguefack-Tsague, Georges
AU - Ngunjiri, Josephine W.
AU - Nguyen, Cuong Tat
AU - Nguyen, Huong Lan Thi
AU - Nnaji, Chukwudi A.
AU - Noubiap, Jean Jacques
AU - Nuñez-Samudio, Virginia
AU - Nwatah, Vincent Ebuka
AU - Oancea, Bogdan
AU - Odukoya, Oluwakemi Ololade
AU - Olagunju, Andrew T.
AU - Olakunde, Babayemi Oluwaseun
AU - Olusanya, Bolajoko Olubukunola
AU - Olusanya, Jacob Olusegun
AU - Bali, Ahmed Omar
AU - Onwujekwe, Obinna E.
AU - Orisakwe, Orish Ebere
AU - Otstavnov, Nikita
AU - Otstavnov, Stanislav S.
AU - Owolabi, Mayowa O.
AU - Mahesh, P. A.
AU - Padubidri, Jagadish Rao
AU - Pana, Adrian
AU - Pandey, Ashok
AU - Pandi-Perumal, Seithikurippu R.
AU - Kan, Fatemeh Pashazadeh
AU - Patton, George C.
AU - Pawar, Shrikant
AU - Peprah, Emmanuel K.
AU - Postma, Maarten J.
AU - Preotescu, Liliana
AU - Syed, Zahiruddin Quazi
AU - Rabiee, Navid
AU - Radfar, Amir
AU - Rafiei, Alireza
AU - Rahim, Fakher
AU - Rahimi-Movaghar, Vafa
AU - Rahmani, Amir Masoud
AU - Ramezanzadeh, Kiana
AU - Rana, Juwel
AU - Ranabhat, Chhabi Lal
AU - Rao, Sowmya J.
AU - Rawaf, David Laith
AU - Rawaf, Salman
AU - Rawassizadeh, Reza
AU - Regassa, Lemma Demissie
AU - Ward, Paul
N1 - Funding Information: S Afzal acknowledges support of the Pakistan Society of Medical Infectious Diseases and King Edward Medical University to access the relevant data of HIV from various sources. T W Bärnighausen was supported by the Alexander von Humboldt Foundation through the Alexander von Humboldt Professor award, funded by the German Federal Ministry of Education and Research. F Carvalho and E Fernandes acknowledge support from Fundação para a Ciência e a Tecnologia (FCT), I.P., in the scope of the project UIDP/04378/2020 and UIDB/04378/2020 of the Research Unit on Applied Molecular Biosciences - UCIBIO and the project LA/P/0140/2020 of the Associate Laboratory Institute for Health and Bioeconomy - i4HB; FCT/MCTES (Ministério da Ciência, Tecnologia e Ensino Superior) through the project UIDB/50006/2020. K Deribe acknowledges support by the Wellcome Trust [grant number 201900/Z/16/Z] as part of his International Intermediate Fellowship. C Herteliu and A Pana are partially supported by a grant of the Romanian National Authority for Scientific Research and Innovation, CNDS-UEFISCDI, project number PN-III-P4-ID-PCCF-2016-0084. Claudiu Herteliu is partially supported by a grant of the Romanian Ministry of Research Innovation and Digitalization, MCID, project number ID-585-CTR-42-PFE-2021. Y J Kim acknowledges support by the Research Management Centre, Xiamen University Malaysia [No. XMUMRF/2020-C6/ITCM/0004]. S L Koulmane Laxminarayana acknowledges institutional support by the Manipal Academy of Higher Education. K Krishan acknowledges non-financial support from UGC Centre of Advanced Study, CAS II, Department of Anthropology, Panjab University, Chandigarh, India. M Kumar would like to acknowledge NIH/FIC K43 TW010716-04. I Landires is a member of the Sistema Nacional de Investigación (SNI), supported by the Secretaría Nacional de Ciencia, Tecnología e Innovación (SENACYT), Panama. V Nuñez-Samudio is a member of the Sistema Nacional de Investigación (SNI), which is supported by Panama’s Secretaría Nacional de Ciencia, Tecnología e Innovación (SENACYT). O O Odukoya was supported by the Fogarty International Center of the National Institutes of Health under the Award Number K43TW010704. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Z Quazi Syed acknowledges support from JNMC, Datta Meghe Institute of Medical Sciences. A I Ribeiro was supported by National Funds through FCT, under the ‘Stimulus of Scientific Employment – Individual Support’ program within the contract CEECIND/02386/2018. A M Samy acknowledges the support from a fellowship of the Egyptian Fulbright Mission program and Ain Shams University. R Shrestha acknowledges support from NIDA K01 Award: K01DA051346. N Taveira acknowledges support from FCT and Aga Khan Development Network (AKDN) - Portugal Collaborative Research Network in Portuguese speaking countries in Africa (project reference: 332821690), and by the European & Developing Countries Clinical Trials Partnership (EDCTP), UE (project reference: RIA2016MC-1615). B Unnikrishnan acknowledges support from Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal. Funding Information: LBD sub-Saharan Africa HIV Prevalence Collaborators S Afzal acknowledges support of the Pakistan Society of Medical Infectious Diseases and King Edward Medical University to access the relevant data of HIV from various sources. T W Bärnighausen was supported by the Alexander von Humboldt Foundation through the Alexander von Humboldt Professor award, funded by the German Federal Ministry of Education and Research. F Carvalho and E Fernandes acknowledge support from Fundação para a Ciência e a Tecnologia (FCT), I.P., in the scope of the project UIDP/04378/2020 and UIDB/04378/2020 of the Research Unit on Applied Molecular Biosciences - UCIBIO and the project LA/P/0140/2020 of the Associate Laboratory Institute for Health and Bioeconomy - i4HB; FCT/MCTES (Ministério da Ciência, Tecnologia e Ensino Superior) through the project UIDB/50006/2020. K Deribe acknowledges support by the Wellcome Trust [grant number 201900/Z/16/Z] as part of his International Intermediate Fellowship. C Herteliu and A Pana are partially supported by a grant of the Romanian National Authority for Scientific Research and Innovation, CNDS-UEFISCDI, project number PN-III-P4-ID-PCCF-2016-0084. Claudiu Herteliu is partially supported by a grant of the Romanian Ministry of Research Innovation and Digitalization, MCID, project number ID-585-CTR-42-PFE-2021. Y J Kim acknowledges support by the Research Management Centre, Xiamen University Malaysia [No. XMUMRF/2020-C6/ITCM/0004]. S L Koulmane Laxminarayana acknowledges institutional support by the Manipal Academy of Higher Education. K Krishan acknowledges non-financial support from UGC Centre of Advanced Study, CAS II, Department of Anthropology, Panjab University, Chandigarh, India. M Kumar would like to acknowledge NIH/FIC K43 TW010716-04. I Landires is a member of the Sistema Nacional de Investigación (SNI), supported by the Secretaría Nacional de Ciencia, Tecnología e Innovación (SENACYT), Panama. V Nuñez-Samudio is a member of the Sistema Nacional de Investigación (SNI), which is supported by Panama’s Secretaría Nacional de Ciencia, Tecnología e Innovación (SENACYT). O O Odukoya was supported by the Fogarty International Center of the National Institutes of Health under the Award Number K43TW010704. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Z Quazi Syed acknowledges support from JNMC, Datta Meghe Institute of Medical Sciences. A I Ribeiro was supported by National Funds through FCT, under the ‘Stimulus of Scientific Employment – Individual Support’ program within the contract CEECIND/02386/2018. A M Samy acknowledges the support from a fellowship of the Egyptian Fulbright Mission program and Ain Shams University. R Shrestha acknowledges support from NIDA K01 Award: K01DA051346. N Taveira acknowledges support from FCT and Aga Khan Development Network (AKDN) - Portugal Collaborative Research Network in Portuguese speaking countries in Africa (project reference: 332821690), and by the European & Developing Countries Clinical Trials Partnership (EDCTP), UE (project reference: RIA2016MC-1615). B Unnikrishnan acknowledges support from Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal. Funding Information: This work was primarily supported by grant OPP1132415 from the Bill & Melinda Gates Foundation. The funder of the study had no role in study design, data collection, data analysis, data interpretation, writing of the report, or decision to publish. The corresponding authors had full access to all the data in the study and had final responsibility for the decision to submit for publication. Funding Information: S Afzal reports leadership or fiduciary role in other board, society, committee or advocacy group, unpaid, with the Pakistan society of Community Medicine & Public Health, the Pakistan Association of Medical Editors, and the Pakistan Society of Medical Infectious Diseases, all outside the submitted work. R Ancuceanu reports 5 payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from Avvie, Sandoz, and B Braun, all outside the submitted work. T W Bärnighausen reports research grants from the European Union (Horizon 2020 and EIT Health), German Research Foundation (DFG), US National Institutes of Health, German Ministry of Education and Research, Alexander von Humboldt Foundation, Else-Kröner-Fresenius-Foundation, Wellcome Trust, Bill & Melinda Gates Foundation, KfW, UNAIDS, and WHO; consulting fees from KfW on the OSCAR initiative in Vietnam; participation on a Data Safety Monitoring Board or Advisory Board with the NIH-funded study “Healthy Options” (PIs: Smith Fawzi, Kaaya), Chair, Data Safety and Monitoring Board (DSMB), German National Committee on the “Future of Public Health Research and Education,” Chair of the scientific advisory board to the EDCTP Evaluation, Member of the UNAIDS Evaluation Expert Advisory Committee, National Institutes of Health Study Section Member on Population and Public Health Approaches to HIV/AIDS (PPAH), US National Academies of Sciences, Engineering, and Medicine’s Committee for the “Evaluation of Human Resources for Health in the Republic of Rwanda under the President’s Emergency Plan for AIDS Relief (PEPFAR),” University of Pennsylvania (UPenn) Population Aging Research Center (PARC) External Advisory Board Member; leadership or fiduciary role in other board, society, committee or advocacy group, paid or unpaid, as co-chair of the Global Health Hub Germany (which was initiated by the German Ministry of Health); all outside the submitted work. J das Neves reports grants or contracts from Ref. 13605 – Programa GÉNESE, Gilead Portugal (PGG/002/2016 – Programa GÉNESE, Gilead Portugal) outside the submitted work. L Dwyer-Lindgren reports support for the present manuscript from the Bill & Melinda Gates Foundation through grant OPP1132415. I Filip reports other financial or non-financial interests from Avicenna Medical and Clinical Research Institute, outside the submitted work. E Haeuser reports support for the present manuscript from the Bill & Melinda Gates Foundation through grant OPP1132415. C Herteliu reports grants from Romanian Ministry of Research Innovation and Digitalization, MCID, for project number ID-585-CTR-42-PFE-2021 (Jan 2022-Jun 2023) “Enhancing institutional performance through development of infrastructure and transdisciplinary research ecosystem within socio-economic domain – PERFECTIS,” from Romanian National Authority for Scientific Research and Innovation, CNDS-UEFISCDI, for project number PN-III-P4-ID-PCCF-2016-0084 (Oct 2018-Sep 2022) “Understanding and modelling time-space patterns of psychology-related inequalities and polarization,” and project number PN-III-P2-2.1-SOL-2020-2-0351 (Jun 2020-Oct 2020) “Approaches within public health management in the context of COVID-19 pandemic,” and from the Ministry of Labour and Social Justice, Romania for project number “Agenda for skills Romania 2020-2025”; all outside the submitted work. J J Jozwiak reports payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from Teva, Amgen, Synexus, Boehringer Ingelheim, Zentiva, and Sanofi as personal fees, all outside the submitted work. J Khubchandani reports other financial interests from Teva Pharmaceuticals, all outside the submitted work. K Krishnan reports other non-financial support from UGC Centre of Advanced Study, CAS II, Department of Anthropology, Panjab University, Chandigarh, India, outside the submitted work. H J Larson reports grants or contracts from the MacArthur Foundation and Merck to London School of Hygeine and Tropical Medicine, and from the Vaccine Confidence Fund to the University of Washington; payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from Center for Strategic and International Studies as payment to LSHTM for co-chairing HighLevel Panel and from GSK as personal payment for developing training sessions and lectures; leadership or fiduciary role in other board, society, committee or advocacy group, pair, with the ApiJect Advisory Board; all outside the submitted work. O O Odukoya reports support for the present manuscript from the Fogarty International Center of the National Institutes of Health under the Award Number K43TW010704. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. A Pans reports grants from Romanian National Authority for Scientific Research and Innovation, CNDS-UEFISCDI, for project number PN-III-P4-ID-PCCF-2016-0084 (Oct 2018-Sep 2022) “Understanding and modelling time-space patterns of psychology-related inequalities and polarization,” and project number PN-III-P2-2.1-SOL-2020-2-0351 (Jun 2020-Oct 2020) “Approaches within public health management in the context of COVID-19 pandemic,” outside the submitted work. S R Pandi-Perumal reports royalties from Springer for editing services; stock or stock options in Somnogen Canada Inc as the President and Chief Executive Officer; all outside the submitted work. A Radfar reports other financial or non-financial interests from Avicenna Medical and Clinical Research Institute, outside the submitted work. A I Ribeiro reports grants or contracts from National Funds through FCT, under the ‘Stimulus of Scientific Employment – Individual Support’ program within the contract CEECIND/02386/2018, outside the submitted work. J M Ross reports support for the present manuscript from the Bill & Melinda Gates Foundation through grant OPP1132415; grants or contracts from National Institutes of Health and Firland Foundation as payments to their institution; consulting fees from United States Agency for International Development as personal payments, and from KNCV Tuberculosis Foundation as payments to their institution; all outside the submitted work. E Rubagotti reports payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from the Greenwich China Office and Unviersity Prince Mohammad VI, Morocco, all outside the submitted work. B Sartorius reports grants or contracts from DHSC – GRAM Project; Leadership or fiduciary role in other board, society, committee or advocacy group, paid or unpaid, as a member of the GBD Scientific Council and a Member of WHO RGHS; all outside the submitted work. J A Singh reports consulting fees from Crealta/Horizon, Medisys, Fidia, PK Med, Two labs Inc, Adept Field Solutions, Clinical Care options, Clearview healthcare partners, Putnam associates, Focus forward, Navigant consulting, Spherix, MedIQ, Jupiter Life Science LLC, UBM LLC, Trio Health, Medscape, WebMD, and Practice Point communications, and the National Institutes of Health and the American College of Rheumatology; payment or honoraria for participating in the speakers bureau for Simply Speaking; support for attending meetings and/or travel from the steering committee of OMERACT, to attend their meeting every 2 years; participation on a Data Safety Monitoring Board or Advisory Board as an unpaid member of the FDA Arthritis Advisory Committee; leadership or fiduciary role in other board, society, committee or advocacy group, paid or unpaid, as a member of the steering committee of OMERACT, an international organization that develops measures for clinical trials and receives arm’s length funding from 12 pharmaceutical companies, with the Veterans Affairs Rheumatology Field Advisory Committee as Chair, and with the UAB Cochrane Musculoskeletal Group Satellite Center on Network Meta-analysis as a director and editor; stock or stock options in TPT Global Tech, Vaxart pharmaceuticals, Atyu Biopharma, Adaptimmune Therapeutics, GeoVax Labs, Pieris Pharmaceuticals, Enzolytics Inc, Series Therapeutics, Tonix Pharmaceuticals, and Charlotte’s Web Holdings Inc. and previously owned stock options in Amarin, Viking, and Moderna pharmaceuticals; all outside the submitted work. N Taveira reports grants or contracts from FCT and Aga Khan Development Network (AKDN) – Portugal Collaborative Research Network in Portuguese speaking countries in Africa (Project reference: 332821690) and from European & Developing Countries Clinical Trials Partnership (EDCTP), UE (Project reference: RIA2016MC-1615), as payments made to their institution, all outside the submitted work. Publisher Copyright: © 2022, The Author(s).
PY - 2022/12
Y1 - 2022/12
N2 - Background: Human immunodeficiency virus and acquired immune deficiency syndrome (HIV/AIDS) is still among the leading causes of disease burden and mortality in sub-Saharan Africa (SSA), and the world is not on track to meet targets set for ending the epidemic by the Joint United Nations Programme on HIV/AIDS (UNAIDS) and the United Nations Sustainable Development Goals (SDGs). Precise HIV burden information is critical for effective geographic and epidemiological targeting of prevention and treatment interventions. Age- and sex-specific HIV prevalence estimates are widely available at the national level, and region-wide local estimates were recently published for adults overall. We add further dimensionality to previous analyses by estimating HIV prevalence at local scales, stratified into sex-specific 5-year age groups for adults ages 15–59 years across SSA. Methods: We analyzed data from 91 seroprevalence surveys and sentinel surveillance among antenatal care clinic (ANC) attendees using model-based geostatistical methods to produce estimates of HIV prevalence across 43 countries in SSA, from years 2000 to 2018, at a 5 × 5-km resolution and presented among second administrative level (typically districts or counties) units. Results: We found substantial variation in HIV prevalence across localities, ages, and sexes that have been masked in earlier analyses. Within-country variation in prevalence in 2018 was a median 3.5 times greater across ages and sexes, compared to for all adults combined. We note large within-district prevalence differences between age groups: for men, 50% of districts displayed at least a 14-fold difference between age groups with the highest and lowest prevalence, and at least a 9-fold difference for women. Prevalence trends also varied over time; between 2000 and 2018, 70% of all districts saw a reduction in prevalence greater than five percentage points in at least one sex and age group. Meanwhile, over 30% of all districts saw at least a five percentage point prevalence increase in one or more sex and age group. Conclusions: As the HIV epidemic persists and evolves in SSA, geographic and demographic shifts in prevention and treatment efforts are necessary. These estimates offer epidemiologically informative detail to better guide more targeted interventions, vital for combating HIV in SSA.
AB - Background: Human immunodeficiency virus and acquired immune deficiency syndrome (HIV/AIDS) is still among the leading causes of disease burden and mortality in sub-Saharan Africa (SSA), and the world is not on track to meet targets set for ending the epidemic by the Joint United Nations Programme on HIV/AIDS (UNAIDS) and the United Nations Sustainable Development Goals (SDGs). Precise HIV burden information is critical for effective geographic and epidemiological targeting of prevention and treatment interventions. Age- and sex-specific HIV prevalence estimates are widely available at the national level, and region-wide local estimates were recently published for adults overall. We add further dimensionality to previous analyses by estimating HIV prevalence at local scales, stratified into sex-specific 5-year age groups for adults ages 15–59 years across SSA. Methods: We analyzed data from 91 seroprevalence surveys and sentinel surveillance among antenatal care clinic (ANC) attendees using model-based geostatistical methods to produce estimates of HIV prevalence across 43 countries in SSA, from years 2000 to 2018, at a 5 × 5-km resolution and presented among second administrative level (typically districts or counties) units. Results: We found substantial variation in HIV prevalence across localities, ages, and sexes that have been masked in earlier analyses. Within-country variation in prevalence in 2018 was a median 3.5 times greater across ages and sexes, compared to for all adults combined. We note large within-district prevalence differences between age groups: for men, 50% of districts displayed at least a 14-fold difference between age groups with the highest and lowest prevalence, and at least a 9-fold difference for women. Prevalence trends also varied over time; between 2000 and 2018, 70% of all districts saw a reduction in prevalence greater than five percentage points in at least one sex and age group. Meanwhile, over 30% of all districts saw at least a five percentage point prevalence increase in one or more sex and age group. Conclusions: As the HIV epidemic persists and evolves in SSA, geographic and demographic shifts in prevention and treatment efforts are necessary. These estimates offer epidemiologically informative detail to better guide more targeted interventions, vital for combating HIV in SSA.
KW - Africa
KW - Demographics
KW - Geostatistics
KW - HIV
KW - HIV prevalence
KW - Mapping
KW - Spatial statistics
UR - http://www.scopus.com/inward/record.url?scp=85144401013&partnerID=8YFLogxK
U2 - 10.1186/s12916-022-02639-z
DO - 10.1186/s12916-022-02639-z
M3 - Article
C2 - 36529768
AN - SCOPUS:85144401013
SN - 1741-7015
VL - 20
JO - BMC Medicine
JF - BMC Medicine
IS - 1
M1 - 488
ER -